Asthma and allergy
Allergy occurs when the immune system in an individual responds to allergens which are substances in condition that don't cause issues for many people. This response prompts irritation (redness and swelling) that causes unfavorably susceptible conditions, which can influence different parts of the body, for example, hypersensitive rhinitis, skin inflammation or urticaria, hypersensitivity and asthma. Individuals with asthma experience a narrowing of the airway routes in the lungs, which obstructs the stream of air into and out of the lungs.
- Dust mites.
- Be short of breath
- Breathe quickly
- Feel your chest get tight
Related Conference of Asthma and allergy
September 23-24, 2024
15th International Conference on Pulmonary & Respiratory Medicine
Singapore City, Singapore
October 24-25, 2024
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Asthma and allergy Conference Speakers
Recommended Sessions
- Asthma and allergy
- Cardiovascular Risk and COPD
- CO-Morbidities in COPD
- COPD Exacerbations
- COPD Management
- Epidemiology of COPD
- Interstitial Lung Disease
- Lung cancer
- Lung Diseases
- Lung Transplantation
- Occupational & Environmental lung Disease
- Pathogenesis of COPD
- Prevention of COPD
- Pulmonary Hypertension
- Pulmonary, Critical care and Sleep
- Respiratory Infections
- Therapeutic Devices and Evaluation
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)